Position in CYTK
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$388,143
+$13,956 QoQ
Shares Held
5,889
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CERTUITY, LLC holds $8,233,390 across 16 Biotechnology names. CYTK ranks #5 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,929 | $2,647,535 | |
| 2 | INCY |
Incyte Corp
|
23,438 | $2,205,984 | |
| 3 | ABSI |
Absci Corp
|
140,697 | $422,091 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
519 | $401,000 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
5,889 | $388,143 | |
| 6 | PVLA |
Palvella Therapeutics, Inc.
|
3,000 | $373,950 | |
| 7 | IMMX |
Immix Biopharma, Inc.
|
35,000 | $318,850 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,170 | $267,614 |
All Filings in CYTK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $388,143 | 5,889 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $374,187 | 5,889 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $362,131 | 6,589 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $369,908 | 9,204 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $244,796 | 5,204 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $266,956 | 5,056 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $273,934 | 5,056 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $350,550 | 5,000 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||